BRIEF published on 04/23/2024 at 22:05, 1 year 7 months ago Evan Shear Achieves Forbes 2024 Best-in-State Wealth Advisors Recognition Financial Planning Evan Shear Forbes 2024 Wealth Advisors CrossleyShear
PRESS RELEASE published on 04/23/2024 at 22:00, 1 year 7 months ago Evan Shear Named to Forbes 2024 Best-in-State Wealth Advisors List CrossleyShear Wealth Management announces Evan Shear's seventh consecutive inclusion in Forbes' Best-in-State Wealth Advisors, a prestigious recognition based on strict criteria Wealth Management Financial Planning CrossleyShear Wealth Management Evan Shear Forbes Best-in-State Wealth Advisors
PRESS RELEASE published on 12/05/2023 at 20:00, 1 year 11 months ago Dale Crossley Named to Raymond James 2024 Chairman’s Council CrossleyShear Wealth Management announced the naming of Dale Crossley, Jr., JD to the Raymond James Chairman's Council, which recognizes top-achieving advisors Wealth Management Financial Planning CrossleyShear Wealth Management Dale Crossley Jr Raymond James Chairman's Council
Published on 12/05/2025 at 02:35, 3 hours 25 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 55 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 30 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 10 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 35 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 45 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 50 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 15 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 16 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 22 hours 59 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
